Hepatic Cell News Volume 6.22 | Jun 17 2022

    0
    17







    2022-06-17 | HCC 6.22


    Hepatic Cell News by STEMCELL Technologies
    Vol. 6.22 – 17 June, 2022
    TOP STORY

    MiR-690 Treatment Causes Decreased Fibrosis and Steatosis and Restores Specific Kupffer Cell Functions in NASH

    MiR-690 directly inhibited fibrogenesis in hepatic stellate cells, inflammation in recruited hepatic macrophages, and de novo lipogenesis in hepatocytes.
    [Cell Metabolism]

    AbstractGraphical Abstract

    Request your free copy of the 'Growing Organoids from Stem Cells' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    FUNDC2 Promotes Liver Tumorigenesis by Inhibiting MFN1-Mediated Mitochondrial Fusion

    Investigators reported that a mitochondrial protein FUN14 domain containing 2 (FUNDC2) was transcriptionally upregulated in primary mouse liver tumors, and in approximately 40% of human HCC.
    [Nature Communications]

    Full Article

    In Vitro Grafting of Hepatic Spheroids and Organoids on a Microfluidic Vascular Bed

    The authors introduced a platform for routine grafting of liver and other tissues on an in vitro grown microvascular bed.
    [Angiogenesis]

    Full Article

    Constitutive Activation of the Tumor Suppressor p53 in Hepatocytes Paradoxically Promotes Non-Cell Autonomous Liver Carcinogenesis

    Scientists found that activation of hepatocyte p53 created a microenvironment prone to tumor formation from hepatic progenitor cells and that optimization of p53 activity in hepatocytes was important to prevent chronic liver disease patients from hepatocarcinogenesis.
    [Cancer Research]

    Abstract

    ATGL-Dependent White Adipose Tissue Lipolysis Controls Hepatocyte PPARα Activity

    Intact PPARα activity in hepatocytes was required for the cross-talk between adipose tissues and the liver during fat mobilization.
    [Cell Reports]

    Full ArticleGraphical Abstract

    Identification of a Novel Calpain-2-SRC Feed-Back Loop As Necessity for β-Catenin Accumulation and Signaling Activation in Hepatocellular Carcinoma

    Investigators reported that Calpain-2 promoted the proliferation and invasion of HCC, and showed a positive correlation with the levels of invasion-related markers.
    [Oncogene]

    Full Article

    M2 Macrophage-Derived Exosomal MicroRNA-411-5p Impedes the Activation of Hepatic Stellate Cells by Targeting CAMSAP1 in NASH Model

    Researchers reported that exosomal miR-411-5p from M2 macrophages inhibited hepatic stellate cells activation and miR-411-5p directly downregulated the expression of calmodulin regulated spectrin associated protein 1 (CAMSAP1) to inactivate stellate cells.
    [iScience]

    AbstractGraphical Abstract

    Identification of Ferroptosis-Related Genes for Overall Survival Prediction in Hepatocellular Carcinoma

    The authors reported that silencing PRDX1 increased the accumulation of ferrous ions and lipid peroxidation accumulation in HEPG2 cells and promoted ferroptosis in hepatocellular carcinoma.
    [Scientific Reports]

    Full Article

    PLIN2 Promotes HCC Cells Proliferation by Inhibiting the Degradation of HIF1α

    Scientists revealed that PLIN2 was frequently upregulated in HCC cells and tissues, and increased PLIN2 expression was associated with poor prognosis outcomes in HCC.
    [Experimental Cell Research]

    Abstract

    Sevoflurane Inhibits Metastasis in Hepatocellular Carcinoma by Inhibiting MiR-665-Induced Activation of the ERK/MMP Pathway

    HepG2 and SMMC7721 cells were treated with 1.7%, 3.4%, and 5.1 % sevoflurane for six hours. Cell migration was analyzed using invasion, migration, and scratch assays.
    [Cell Transplantation]

    Full Article

    Subscribe to Science News for free weekly science newsletters.
    REVIEWS

    COVID-19 and Liver Disease

    Investigators review COVID-19 liver manifestations and pathophysiological aspects related to SARS-CoV-2 infection in patients without liver disease as well as the impact of COVID-19 in patients with chronic liver disease, particularly cirrhosis and liver transplantation.
    [Gut]

    Full Article

    Immune Therapies against Chronic Hepatitis B

    The authors discuss the pros and cons of different immune therapies, observed in patients with chronic hepatitis B (CHB) during the last 30 years, to derive insights into the development of an evidence-based, effective, and patient-friendly regimen of immune therapy for the treatment of CHB.
    [Journal of Gastroenterology]

    Full Article

    Syndecan-1 in Liver Pathophysiology

    Syndecan-1 represents the major proteoglycan of the liver, expressed by hepatocytes and cholangiocytes, and its elevated expression is a characteristic feature of liver diseases.
    [American Journal of Physiology-Cell Physiology]

    Abstract

    INDUSTRY AND POLICY NEWS

    Surrozen Initiates Dosing in Phase I Clinical Trial of SZN-043 for Severe Alcoholic Hepatitis

    Surrozen, Inc. announced that the first subject has been dosed in its two-part Phase I clinical trial for SZN-043 which is in development for the potential treatment of severe alcoholic hepatitis.
    [Surrozen, Inc.]

    Press Release

    FEATURED EVENT

    Danish Stem Cell Society (DASCS) 2022

    September 19 – 20, 2022
    Vejle, Denmark

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Fellow – Computational Analysis of Human Microbiome Data

    European Molecular Biology Laboratory – Heidelberg, Germany

    Postdoctoral Associate – Lung and Liver Injury in Sickle Cell Disease

    University of Pittsburgh School of Medicine – Pittsburgh, Pennsylvania, United States

    Postdoctoral Candidate – Cancer Biology

    German Cancer Research Center in the Helmholtz Association – Heidelberg, Germany

    Postdoctoral Fellow – Cancer Immunology & Genomics

    La Jolla Institute for Immunology – La Jolla, California, United States

    PhD Candidate – Cellular and Molecular Mechanisms of Cancer

    Norwegian University of Science and Technology -Trondheim, Norway

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Hepatic Cell News Twitter